Efficacy of Alkalinized Lidocaine in the Endotracheal Tube Cuff on the Incidence of Coughing During Emergence
Study Details
Study Description
Brief Summary
This study is designed to compare the efficacy of endotracheal tube cuffs pre-filled with alkalinized lidocaine on the:
-
incidence of coughing during emergence of general anesthesia
-
time needed for emergence following a desflurane-based anesthesia
-
incidence of sore throat after extubation.
The investigator's hypothesis is that the use of endotracheal tube cuffs pre-filled with alkalinized lidocaine will reduce the incidence of coughing by 50% relative to a control group following a desflurane-based anesthesia.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Emergence is an important period of general anesthesia during which several problems can occur. Coughing, hypertension, tachycardia and agitation have been observed during emergence of general anesthesia.
Desflurane is a newer volatile agent allowing early recovery from anesthesia. This agent has led to earlier discharge and more rapid resumption of normal activities after surgery. However, an incidence of coughing around 70% has been reported after a desflurane-based anesthesia. Different techniques and drugs have been studied to reduce coughing during emergence.
Among others, the role of lidocaine given intravenously, topically, or intracuff has been studied. Intracuff lidocaine has been shown to increase the tolerance to the endotracheal tube without reducing the swallowing reflex. However, lidocaine slowly diffuses across the tube's cuff. The addition of bicarbonates is required to increase its diffusion to the underlying tracheal tissue. Alkalinization of lidocaine allows the diffusion of 65% of its neutral base form over a period of 6 hours.
In vitro studies have demonstrated that the optimal time for local anesthetic diffusion through the cuff may vary from 90 to 180 minutes. Due to its low onset, this technique would be appropriate for long-duration surgeries. Pre-filling the endotracheal tube cuffs with alkalinized lidocaine at least 90 minutes before intubation could be appropriate for surgeries expected to last less than two hours.
This study will assess the efficacy of pre-filling endotracheal tube cuffs with alkalinized lidocaine to prevent coughing during emergence in short-duration surgeries.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Alkalinized lidocaine The endotracheal tube cuff will be pre-filled at least 90 minutes before intubation with alkalinized lidocaine. Endotracheal tube cuff will be emptied before intubation and then re-filled with the same mixture following intubation to secure the position of the endotracheal tube. (cuff will be inflated until there is no air leak around the tube). During emergence, when the expired fraction of desflurane reaches 0.2 MAC, the patient will be asked to open his eyes every 30 seconds. Any coughing effort before 0.2 MAC will be considered as a treatment failure and the patient will be treated according to the attending anaesthesiologist. |
Drug: Alkalinized lidocaine
Administration of alkalinized lidocaine in the endotracheal tube cuff
|
| Placebo Comparator: Saline The endotracheal tube cuff will be pre-filled at least 90 minutes before intubation with saline. Endotracheal tube cuff will be emptied before intubation and then re-filled with the same mixture following intubation to secure the position of the endotracheal tube. (cuff will be inflated until there is no air leak around the tube). During emergence, when the expired fraction of desflurane reaches 0.2 MAC, the patient will be asked to open his eyes every 30 seconds. Any coughing effort before 0.2 MAC will be considered as a treatment failure and the patient will be treated according to the attending anaesthesiologist. |
Drug: Saline
Administration of saline in the endotracheal tube cuff
|
Outcome Measures
Primary Outcome Measures
- Incidence of coughing during emergence of general anesthesia [At extubation (Day 0)]
Secondary Outcome Measures
- Time to emergence [At extubation (Day 0)]
- Incidence of sore throat [One hour after extubation (Day 0)]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients undergoing elective short-duration surgery under general anesthesia (expected duration of less than 2 hours)
-
Physical status 1-3
Exclusion Criteria:
-
Asthma or severe pulmonary disease
-
Pulmonary tract infection
-
Anticipated difficult intubation
-
Current use of cough medicine
-
Contraindication to lidocaine
-
Pregnancy
-
Airway surgery
-
Inability to provide informed consent
-
Patient refusal
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Centre Hospitalier de l'Université de Montréal | Montreal | Quebec | Canada | H2L 4M1 |
Sponsors and Collaborators
- Centre hospitalier de l'Université de Montréal (CHUM)
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Investigators
- Principal Investigator: Nathalie Massicotte, MD, FRCPC, Centre Hospitalier de l'Université de Monrtréal
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NM2012-003